IL17A AND IL17R POLYMORPHISMS AND CCL2, IL-17A AND IL-33 STATUS IN THE PATIENTS WITH DIFFERENT CLINICAL MANIFESTATIONS OF TOXOPLASMOSIS IN THE STATE OF RIO GRANDE DO NORTE, BRAZIL
Toxoplasma gondii, Gene polymorphism, cytokines, IL17, Clinical Manifestations.
Toxoplasmosis is an infectious parasitic disease caused by Toxoplasma gondii, which can have serious consequences when it affects immunocompromised patients and/or vertically infected fetuses, triggering encephalitis, chorioretinitis, and neurological/psychiatric disorders. In this study, we evaluated polymorphisms for the IL17A and IL17R genes, as well as the status of CCL2, IL-17A, and IL-33 from patients with different clinical manifestations of toxoplasmosis in the State of Rio Grande do Norte. The results obtained for IL-17A show SNPs in the promoter region of its IL17A gene, rs2275913-197 G> A, which has been implicated in the production of elevated levels of IL-17A; as well as SNPs rs4819554 (A> G) in the gene responsible for encoding its receptor, IL-17RA. Such polymorphisms associated with CCL2 and IL-33 levels show important repercussions for the individuals evaluated in this study, especially in ocular toxoplasmosis, a fact that was not clearly observed in gestational toxoplasmosis. This work, therefore, opens perspectives for a better knowledge of the immunomodulation promoted by T. gondii, in the population of Rio Grande do Norte.